Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination

Guillain-Barré syndrome after Pfizer and Astra-Zeneca vaccinations against COVID-19 has been previously reported in the literature. The objective of this study was to report the first case of Guillain-Barré following the COVID-19 vaccination with the Johnson & Johnson COVID-19 vaccine. We report...

Descripción completa

Detalles Bibliográficos
Autores principales: Carranza, Octavio, Babici, Denis, Waheed, Sadia, Yousuf, Fawad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117845/
https://www.ncbi.nlm.nih.gov/pubmed/35602794
http://dx.doi.org/10.7759/cureus.24252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117845/
https://www.ncbi.nlm.nih.gov/pubmed/35602794
http://dx.doi.org/10.7759/cureus.24252

Ejemplares similares